# UK Spinout Equity Fell to a Decade Low. For Software Founders, It Did Not Fall Far Enough. **Faraz Rizvi** *Faraz Rizvi is a UK operator-practitioner writing about the work between a research breakthrough and a fundable company. He runs SpinUp Forge.* --- The Royal Academy of Engineering published its Spotlight on Spinouts 2026 report in the first week of June, and the headline figure landed where the reform advocates wanted it: average university founding equity across UK spinouts has fallen to 16%, a decade low, down from 22% in 2023 ([RAEng, Spotlight on Spinouts 2026](https://raeng.org.uk/news/spotlight-on-spinouts-2026)). That is a measured market outcome compiled from Dealroom data across more than 2,000 UK spinouts formed since 2010 — not an aspiration, not a policy target, but what actually happened. The reaction was predictable. The convergence narrative — that post-reform, post-USIT, university equity would settle into the bands the 2023 Independent Review and TenU guidance recommended — now has hard data behind it. The system is working. For life sciences, it is. For software, it is not. ## The convergence that is not converging *Life sciences equity has reached the recommended bands. Software spinouts have not moved.* The RAEng's sector data shows life-sciences equity converging toward the USIT bands of 10–25%, with the strongest exits — OrganOx at approximately $1.5 billion, Oxford Ionics at approximately $1.1 billion ([RAEng, Spotlight on Spinouts 2026](https://raeng.org.uk/news/spotlight-on-spinouts-2026)) — coming from spinouts where the university held stakes below the pre-reform average. The correlation is not subtle: the RAEng's Enterprise Hub analysis found that exited spinouts had a median university stake of 10%, while spinouts that ceased operations had a median stake of 15% ([RAEng Enterprise Hub, "Mapping equity to outcomes"](https://raeng.org.uk/news/spotlight-on-spinouts-2026)). Spinouts with university stakes below 15% had a survival rate of 85.5%, compared to 76.4% for those with stakes above 40%. Software spinouts sit at approximately 17% average university equity — above the sector-wide average, and well above TenU's recommended ceiling of 10% for software. The USIT for Software framework, published May 2024 at Mansion House and co-authored by Cambridge, Edinburgh, Imperial, Manchester, Oxford, and UCL, recommended founders retain 90–95% equity in software spinouts on the explicit basis that IP plays a smaller role in software company value creation than in life sciences ([TenU, USIT for Software](https://www.ten-u.org/news/usit-for-software)). The framework had ministerial attendance. It had VC co-authors — IQ Capital, Cambridge Innovation Capital, Octopus Ventures, Oxford Science Enterprises. The recommendation was 5–10%. The measured outcome, two years later, is 17%. The gap between 10% and 17% is not seven percentage points of dilution. It is a structural mismatch between what the term sheet prices and what a software company's value-creation model requires. ## Why the gap persists *TTOs apply a single equity model to fundamentally different value-creation structures.* The TenU framework named the structural reason software founders should retain more equity: "Software businesses evolve through relentless engagement with customers, understanding their new needs and spotting where the technical advantages of the software can deliver some distinctive performance. This different distribution of value between founding IP and accumulated founder-customer interaction contributes to the justification for different founding equity stake" ([TenU, USIT for Software](https://www.ten-u.org/news/usit-for-software)). In a life-sciences spinout, the university's IP — patent families, licence schedules, regulatory data packages — is load-bearing through to exit. The founding equity stake is, in part, a price for the protected IP that the company cannot function without. In a software spinout, the IP is typically the starting condition, not the compounding asset. The compounding asset is the product the founders build on top of it, the customer relationships they develop, and the operational cadence they establish. By month twelve, the software itself has usually diverged from the original research contribution enough that the founding IP is historical context, not active competitive advantage. The mismatch persists because most TTOs do not run separate equity models for software and non-software spinouts. The negotiation defaults to the institutional template — a template designed around life-sciences IP protection timelines, IP assignment complexity, and the capital structures that characterise regulated-product development. When a software founder meets that template, the result is predictable: an equity stake calibrated to a value-creation model the company will not follow. David Woolley at the University of Southampton named the institutional logic from the other side in a Global University Venturing interview: when Southampton reduced its standard equity from 33% to 10%, the reasoning was that the old terms produced too few spinouts ([Global University Venturing, "UK universities spinout equity stakes"](https://globalventuring.com/university/europe/uk-universities-spinout-equity-stakes/)). That is a volume argument, but it is also an outcome argument. The RAEng's equity-to-outcome data confirms the pattern: lower-equity spinouts survive and exit at higher rates. The causal direction is debatable — lower stakes may attract stronger founders, or stronger founders may negotiate lower stakes — but the correlation between lower university equity and better spinout outcomes is now measured, not assumed. ## What seven percentage points actually costs *The cost is not the dilution itself. It is the speed the dilution consumes.* For a pre-seed software spinout expecting to raise a seed round within twelve months of licence execution, seven extra percentage points of university equity is not primarily a dilution problem. It is a speed problem. Every point above the published benchmark adds friction in two places. First, the negotiation itself. Kerry Baldwin of IQ Capital, contributing to the USIT for Software guide, named speed as the structurally relevant variable: "Speed… matters greatly. The faster a minimum viable product can be tested and launched, the faster product can go to market" ([TenU, USIT for Software](https://www.ten-u.org/news/usit-for-software)). Ian Lane of Cambridge Innovation Capital named the investor-side consequence: "Investors hate uncertainty… If it is uncertain whether a university will take 2% or 40%, it is hard" to commit at the speed the market requires ([TenU, USIT for Software](https://www.ten-u.org/news/usit-for-software)). The TenU framework recommended deal finalisation within three months of receiving a term sheet. The measured average, at 17% equity, suggests those three months are not happening for software spinouts. Second, the cap table at the point of seed. The [Piece 1](funding-system-changed-its-question.html) argument in this series — that the funding system has shifted its question from "is this science good?" to "can this team operate a company?" — applies with particular force to software spinouts, because the operational maturity demanded by programmes like Innovate UK's Velocity is precisely the kind of execution evidence that a software spinout's speed advantage should produce. A university stake of 17% at founding, before any angel or pre-seed dilution, leaves the founder with a cap table that is already tight before the institutional conversation that demands operational evidence has begun. The founders most affected by this gap are the founders most likely to build fast. That is the structural irony: the sector where speed matters most is the sector where the terms framework has converged least. ## What the founding team controls *The terms argument is not won in policy. It is won in the board pack.* There are two responses to this data. The first is to wait for TTO practice to catch up with TenU guidance — which it may, on the same timeline life sciences equity took, over the next two to three years. The second is to build the operational evidence that makes the case for different terms concrete rather than aspirational. The second response is the one the founding team controls. The operational substrate described in [Piece 3](operator-substrate-first-18-months.html) of this series — named workflows with typed inputs and outputs, a structured knowledge layer, eval and observability, on-demand skills — is not only a survival tool for the seed window. It is the single most legible signal a software founding team can present to a TTO when the equity conversation begins. A founder who arrives at that conversation with six months of consistent board packs, a rolling customer-discovery synthesis, a versioned financial model, and an IP register the TTO can read is not asking for lower equity on principle. They are demonstrating that the value creation in this company is already happening in the execution layer — the layer the founders own — not in the founding IP. The RAEng data on equity and outcomes suggests the investor market has already internalised this logic: lower-equity spinouts survive and exit at higher rates. The TTO market has not yet internalised it for software specifically, but the data is now public for the conversation. ## The gap the Venture Builder pilot does not fill *The first government-backed pre-formation programme targets the right stage but does not fund the operator.* Innovate UK's Venture Builder pilot — £3.75 million, up to £150,000 per project, three sectors (Frontier AI, Engineering Biology, Advanced Materials and Manufacturing) — sent EOI-stage outcome notifications in the first week of June 2026 ([UKRI, Venture Builder Pilot](https://www.ukri.org/opportunity/innovate-uk-venture-builder-pilot-expression-of-interest/)). The funded stage runs October 2026 to June 2027 and is the first government-backed programme specifically targeting pre-company-formation deep-tech spinouts. The programme names the right problem — the gap between research insight and incorporated spinout — and sits before accelerators and seed funds in the formation pipeline. But the grant terms, as published, do not include a named operator-cost line. The £150,000 unit funds nine months of investability-building: governance frameworks, commercial strategy, financial modelling, the operational scaffolding that turns a research group into a company. If the founding team cannot hire or commission that capability within the grant terms, the nine months will produce technical milestones rather than the operational substrate the programme's own stated purpose implies. For software spinouts specifically, the Venture Builder pilot's sector choices include Frontier AI — the sector where the equity gap is directly relevant. A Frontier AI spinout entering the pilot with a 17% university stake, no operator budget in the grant, and nine months to reach investability faces two structural constraints simultaneously: equity terms that do not match its value-creation model, and a grant that does not fund the execution capacity needed to build the operational case for different terms. ## What the data now permits *A software founder with the RAEng report and the USIT for Software guide can name the gap in numbers, not frustration.* Before June 2026, the argument for lower software-spinout equity was policy guidance backed by VC preferences. After the RAEng Spotlight report, it is policy guidance backed by measured outcomes. The difference matters because TTO conversations are institutional conversations, and institutions respond to data more readily than to founder frustration. A software founder entering a TTO equity negotiation in the second half of 2026 has three specific artefacts available. The TenU USIT for Software framework, co-authored by six leading TTOs, recommending 5–10% equity for software spinouts. The RAEng Spotlight on Spinouts 2026, showing that the UK average has fallen to 16% and that software-specific equity remains at approximately 17%. And the RAEng Enterprise Hub's equity-to-outcome analysis, showing that lower-equity spinouts survive and exit at higher rates. Those three artefacts, combined with the founder's own operational evidence — the substrate, the board pack, the versioned model — constitute a case, not a complaint. The first conversation with the TTO is not "the terms should be lower." It is "here is what TenU recommends, here is where the sector currently sits, here is what the outcome data shows, and here is the operational track record that demonstrates this company's value accretes in the execution layer." Whether the TTO adjusts is a TTO decision. That the data now exists to make the case legibly is a structural change in the founding team's position. It happened in the first week of June 2026. ## Paired prompt kit **[Term benchmark: prepare the equity conversation](/toolkit/term-benchmark/index.html)**, One prompt that maps your proposed or expected terms against the RAEng and TenU benchmarks, names the operational evidence that strengthens the case, and produces a one-page preparation brief for the TTO conversation. ## Sources - [RAEng, Spotlight on Spinouts 2026](https://raeng.org.uk/news/spotlight-on-spinouts-2026) - [RAEng Enterprise Hub, "Mapping equity to outcomes"](https://raeng.org.uk/news/spotlight-on-spinouts-2026) - [TenU, USIT for Software ("Blueprint For Boosting UK Software Spinouts")](https://www.ten-u.org/news/usit-for-software) - [Global University Venturing, "UK universities spinout equity stakes"](https://globalventuring.com/university/europe/uk-universities-spinout-equity-stakes/) - [UKRI, Innovate UK Venture Builder Pilot: Expression of Interest](https://www.ukri.org/opportunity/innovate-uk-venture-builder-pilot-expression-of-interest/) --- *Sourcing and assumption notes: The 16% UK-average and approximately 17% software-average equity figures are from the RAEng Spotlight on Spinouts 2026 report (Dealroom data, published approximately 3 June 2026). The equity-to-outcome survival-rate figures (85.5% low-stake vs 76.4% high-stake) are from the RAEng Enterprise Hub's "Mapping equity" analysis; the causal direction is explicitly flagged as debatable in the text. The TenU USIT for Software 5–10% recommendation is from the published framework (May 2024). The IUK Venture Builder pilot grant terms and sector choices are from the UKRI opportunity page; the observation that the terms do not include a named operator-cost line is a reading of the published eligibility criteria, not a private disclosure. The Piece 1 and Piece 3 references are to published SpinUp Forge thought pieces. The OrganOx and Oxford Ionics exit valuations are as reported by RAEng; "approximately" qualifies both figures.*